Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Wai Chun Bio-Technology Ltd. ( (HK:0660) ) has shared an update.
Wai Chun Bio-Technology Ltd. announced a delay in the dispatch of a circular related to a connected transaction involving the issuance of new convertible bonds under a specific mandate. The circular, which includes details of the subscription, recommendations, and notices, was initially expected to be sent by July 31, 2025, but will now be dispatched by August 15, 2025, due to the need for additional time to finalize information. This delay may impact the company’s timeline for the transaction and could have implications for its stakeholders and market positioning.
More about Wai Chun Bio-Technology Ltd.
Wai Chun Bio-Technology Ltd. is a company incorporated in the Cayman Islands, operating in the biotechnology sector. It focuses on the development and issuance of financial instruments such as convertible bonds, which are aimed at raising capital for its operations and strategic initiatives.
Average Trading Volume: 182,860
Technical Sentiment Signal: Buy
Current Market Cap: HK$24.99M
For detailed information about 0660 stock, go to TipRanks’ Stock Analysis page.